Pro Medicus Limited
ASX: PME
PME’s growth rates remain extraordinary.
(Source: TradingView) 3-Month Performance Profile of PME compared to the S&P/ASX 200 (XJO).
Pro Medicus has demonstrated remarkable financial growth, with revenue increasing from $56.8 million in 2020 to $161 million in 2024, and earnings rising from $23 million to $82 million. This growth has been accompanie
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
